![\"Welcome](\"http:\/\/blogs.uakron.edu\/ualawip\/wp-content\/uploads\/sites\/1670\/2026\/06\/Welcome-to-IPPI-banner-dark-June-30-2026.png\")
<\/h1>\n<\/div>\n
\nRecent and Upcoming Highlights<\/span><\/span><\/strong><\/h2>\n\n
\nNow Open: Annual Call for Proposals <\/strong>for 2027-2028 Edison Fellowship Program<\/strong><\/h3>\nApply by November 30, 2026<\/strong><\/span><\/p>\nLearn more about the Fellowship and how to apply<\/strong><\/span><\/a><\/p>\n
\nIPPI 2026 Fall Progress Report<\/strong><\/h3>\n(June – August 2026)<\/strong><\/span><\/p>\nRead the report<\/strong><\/span><\/a><\/p>\n
\n <\/p>\n<\/div>\n
\nOctober 7 Webinar: <\/b>“<\/strong>The Future of Copyright\u2019s Substantial Similarity Doctrine: <\/strong>Insights from the En Banc Rehearing in Sedlik v. Von Drachenberg<\/em><\/strong>“<\/strong><\/h3>\n\n![\"Hyperlinked](\"http:\/\/blogs.uakron.edu\/ualawip\/wp-content\/uploads\/sites\/1670\/2026\/09\/Thumbnail-of-Flyer-for-IPPI-October-7-2026-Sedlik-Webinar-corrected.jpg?w=232\")
<\/a>Click image to view flyer<\/figcaption><\/figure>\nWednesday, October 7, 2026<\/b><\/span>
\n1:30-3:00 p.m. Eastern \/ <\/b>10:30 a.m.-12:00 Noon Pacific<\/b><\/span><\/p>\nJoin counsel and amici participating in\u00a0Sedlik v. Von Drachenberg<\/em>, No. 24-3367 (9th Cir. 2026) for an analysis of the Ninth Circuit\u2019s en banc rehearing just days after oral argument.<\/p>\nLearn more, register, and pre-submit questions.<\/span><\/strong><\/a><\/p>\nWebinar will not be recorded. Please join us live!<\/strong><\/p>\n<\/div>\n <\/p>\n
\n
\nNew Blog Post:<\/strong> “Proposed Litigation Funding Disclosure Rules at the U.S. International Trade Commission”<\/strong><\/h3>\nBy Michael Doane | July 20, 2026<\/strong><\/span><\/p>\nRead the blog post<\/strong><\/span><\/a><\/p>\n
\nRecent Letters and Comments by IPPI or Affiliates (June & July 2026)<\/strong><\/h3>\n<\/div>\n\n- MAPIA (June 16, 2026): <\/strong>Letter to Chairman Cassidy and Ranking Member Sanders RE: the Medication Affordability and Patent Integrity Act (MAPIA)<\/a><\/span><\/li>\n
- ITC Nomination (June 24, 2026):<\/strong>Academic Letter in Support of Pappas Nomination June 2026, “RE: Nomination of Peter-Anthony Pappas to U.S. International Trade Commission”<\/a><\/span><\/li>\n
- Michael L. Doane (June 26, 2026)<\/strong>,\u00a0\u201cComments on Notice of Proposed Rule Making, Docket No. MISC-051, 91 Fed. Reg. 23190 (April 30, 2026)\u201d to the U.S. International Trade Commission<\/a><\/span><\/li>\n
- Office of Management and Budget (July 13, 2026):<\/strong>“Comment on Proposed Rule OMB-2026-0034” to the U.S. Office of Management and Budget<\/a><\/span><\/li>\n
- Letter on PERA (July 13, 2026):<\/strong>“Letter of Patent Law and Innovation Scholars in Support of the Patent Eligibility Restoration Act (PERA)” to the U.S. Senate Committee on the Judiciary<\/a><\/span><\/li>\n<\/ul>\n\n
\nNew Blog Post:<\/strong> “Nominations to the U.S. International Trade Commission – A Complete Slate of Commissioners (Almost)”<\/strong><\/h3>\nBy Michael Doane | June 30, 2026<\/strong><\/span><\/p>\nRead the blog post<\/strong><\/span><\/a><\/p>\n
\nIPPI 2026 Summer Progress Report<\/strong><\/h3>\n(March – May 2026)<\/strong><\/span><\/p>\nRead the report<\/strong><\/span><\/a><\/p>\n
\nJune 18 Webinar: <\/b>“The Myths and Realities of Pharmaceutical Patents”<\/strong><\/h3>\nIn an exclusive webinar on Thursday, June 18th, 2026,<\/strong> IPPI scholars examined the myths and realities of pharmaceutical patents.<\/span><\/p>\nThe conversation featured Mark Schultz<\/strong> (Faculty Chair & Senior Scholar, IPPI) and Emily Michiko Morris<\/strong> (Associate Faculty Chair, Senior Fellow for Life Sciences, & Senior Scholar, IPPI) and was moderated by Chris Israel<\/strong> (Executive Director of the Alliance of U.S. Startups & Inventors for Jobs).<\/span><\/p>\nIn the wake of the recent House Judiciary Committee hearing on “Medicines and IP: Balancing Innovation and Access,” the panel unpacked prevailing narratives surrounding pharmaceutical patenting, innovation, and generic competition. Drawing on new IPPI research<\/a> on so-called “patent thickets” and “evergreening,” the discussion examined how pharmaceutical patents reflect the complex, ongoing process of developing and improving medicines — and why simplistic patent counting and common critiques of pharmaceutical patenting often fail to align with real-world evidence.<\/span><\/p>\n
\nJune 10 Webinar: <\/b>“IP at America’s 250th”<\/strong><\/h3>\nJoin us on Wednesday, June 10, from 1:00-2:30 PM EDT, for \u201cIP at America\u2019s 250th,\u201d a virtual panel co-hosted by the Council for Innovation Promotion<\/a> and IPPI: The IP Policy Institute as part of the WIPO-U.S. Summer School on IP<\/a>!<\/span><\/p>\nAmerica was born innovative. The Founders embedded intellectual property protection directly into the Constitution, and for 250 years the nation’s patent, copyright, trademark, and trade secret laws have powered everything from the cotton gin to the smartphone, and from the first American novel to the global entertainment industry.<\/span><\/p>\nThis panel marks America’s 250th by telling the story of IP from the ground up. Whether you’re a practitioner, a policy wonk, or simply curious about the legal foundations of American ingenuity, you won’t want to miss this conversation with a group of seasoned IP experts, including Victoria Cundiff<\/a>, David Gooder<\/a>, The Hon. Andrei Iancu<\/a>, and Karyn Temple<\/a> as panelists, with Joshua Kresh<\/a> as moderator.<\/span><\/p>\n
\nNew Policy Research on the Myths of
\n“Patent Thickets” and “Evergreening”<\/strong><\/h3>\nWe\u2019re pleased to share\u00a0new policy research by IPPI scholars that separates myth from reality in current debates over pharmaceutical patents.<\/span><\/p>\nIn this\u00a0collection of short papers<\/a>\u2014”Pharmaceutical ‘Patent Thickets’ <\/strong>and\u00a0“Pharmaceutical Patent ‘Evergreening'”<\/strong>\u2014Mark Schultz<\/strong> and Douglas Park<\/strong> of IPPI: The Intellectual Property Policy Institute at The University of Akron School of Law, together with\u00a0Jennifer Brant<\/strong>, IPPI Practitioner in Residence and Senior Advisor at Sidley, challenge common narratives about pharmaceutical patenting practices with real-world evidence.<\/span><\/p>\n
\n2026 WIPO-U.S. Summer School on IP<\/strong><\/h3>\n![\"IPPI](\"http:\/\/blogs.uakron.edu\/ualawip\/wp-content\/uploads\/sites\/1670\/2026\/03\/Header_WIPO-US-2026.png?w=790\")
<\/a><\/figure>\nLearn more<\/strong><\/span><\/a><\/p>\n
\nBlog Post: “If AI Can Pirate the Internet, Why Can\u2019t You?”<\/strong><\/h3>\nBy David Atkinson | May 11, 2026<\/strong><\/span><\/p>\nRead the blog post<\/a><\/strong><\/span><\/p>\n
\nBlog Post: “Most-Favored-Nation (MFN) Drug Pricing: You Can\u2019t Import European Prices Without Importing European Tradeoffs”<\/strong><\/h3>\nBy Dr. Gabriela Lenarczyk | May 4, 2026<\/span><\/strong><\/p>\nRead the blog post<\/span><\/strong><\/a><\/p>\n
\nIPPI 2026 Spring Progress Report<\/strong><\/h3>\n(December 2025 – February 2026)<\/strong><\/span><\/p>\nRead the report<\/strong><\/a><\/span><\/p>\n
\nIPPI 2026 Winter Institute:<\/strong>
\n IP and National Success<\/em><\/strong><\/h3>\n![\"Photo](\"http:\/\/blogs.uakron.edu\/ualawip\/wp-content\/uploads\/sites\/1670\/2025\/11\/Buchtel-Blue_APPROVED_Social-Media-Banner_IPPI-2026-Winter-Institute.png?w=580\")
<\/a><\/figure>\nHosted in partnership with<\/span>
\nThe University of Akron School of Law’s Winter Institute 2026<\/a><\/span><\/p>\nThursday, February 26, 2026<\/strong><\/span><\/p>\n
\n
Now Open: Annual Call for Proposals <\/strong>for 2027-2028 Edison Fellowship Program<\/strong><\/h3>\nApply by November 30, 2026<\/strong><\/span><\/p>\nLearn more about the Fellowship and how to apply<\/strong><\/span><\/a><\/p>\n
\nIPPI 2026 Fall Progress Report<\/strong><\/h3>\n(June – August 2026)<\/strong><\/span><\/p>\nRead the report<\/strong><\/span><\/a><\/p>\n
\n <\/p>\n<\/div>\n
\nOctober 7 Webinar: <\/b>“<\/strong>The Future of Copyright\u2019s Substantial Similarity Doctrine: <\/strong>Insights from the En Banc Rehearing in Sedlik v. Von Drachenberg<\/em><\/strong>“<\/strong><\/h3>\n\n<\/a>Click image to view flyer<\/figcaption><\/figure>\nWednesday, October 7, 2026<\/b><\/span>
\n1:30-3:00 p.m. Eastern \/ <\/b>10:30 a.m.-12:00 Noon Pacific<\/b><\/span><\/p>\nJoin counsel and amici participating in\u00a0Sedlik v. Von Drachenberg<\/em>, No. 24-3367 (9th Cir. 2026) for an analysis of the Ninth Circuit\u2019s en banc rehearing just days after oral argument.<\/p>\nLearn more, register, and pre-submit questions.<\/span><\/strong><\/a><\/p>\nWebinar will not be recorded. Please join us live!<\/strong><\/p>\n<\/div>\n <\/p>\n
\n
\nNew Blog Post:<\/strong> “Proposed Litigation Funding Disclosure Rules at the U.S. International Trade Commission”<\/strong><\/h3>\nBy Michael Doane | July 20, 2026<\/strong><\/span><\/p>\nRead the blog post<\/strong><\/span><\/a><\/p>\n
\nRecent Letters and Comments by IPPI or Affiliates (June & July 2026)<\/strong><\/h3>\n<\/div>\n\n- MAPIA (June 16, 2026): <\/strong>Letter to Chairman Cassidy and Ranking Member Sanders RE: the Medication Affordability and Patent Integrity Act (MAPIA)<\/a><\/span><\/li>\n
- ITC Nomination (June 24, 2026):<\/strong>Academic Letter in Support of Pappas Nomination June 2026, “RE: Nomination of Peter-Anthony Pappas to U.S. International Trade Commission”<\/a><\/span><\/li>\n
- Michael L. Doane (June 26, 2026)<\/strong>,\u00a0\u201cComments on Notice of Proposed Rule Making, Docket No. MISC-051, 91 Fed. Reg. 23190 (April 30, 2026)\u201d to the U.S. International Trade Commission<\/a><\/span><\/li>\n
- Office of Management and Budget (July 13, 2026):<\/strong>“Comment on Proposed Rule OMB-2026-0034” to the U.S. Office of Management and Budget<\/a><\/span><\/li>\n
- Letter on PERA (July 13, 2026):<\/strong>“Letter of Patent Law and Innovation Scholars in Support of the Patent Eligibility Restoration Act (PERA)” to the U.S. Senate Committee on the Judiciary<\/a><\/span><\/li>\n<\/ul>\n\n
\nNew Blog Post:<\/strong> “Nominations to the U.S. International Trade Commission – A Complete Slate of Commissioners (Almost)”<\/strong><\/h3>\nBy Michael Doane | June 30, 2026<\/strong><\/span><\/p>\nRead the blog post<\/strong><\/span><\/a><\/p>\n
\nIPPI 2026 Summer Progress Report<\/strong><\/h3>\n(March – May 2026)<\/strong><\/span><\/p>\nRead the report<\/strong><\/span><\/a><\/p>\n
\nJune 18 Webinar: <\/b>“The Myths and Realities of Pharmaceutical Patents”<\/strong><\/h3>\nIn an exclusive webinar on Thursday, June 18th, 2026,<\/strong> IPPI scholars examined the myths and realities of pharmaceutical patents.<\/span><\/p>\nThe conversation featured Mark Schultz<\/strong> (Faculty Chair & Senior Scholar, IPPI) and Emily Michiko Morris<\/strong> (Associate Faculty Chair, Senior Fellow for Life Sciences, & Senior Scholar, IPPI) and was moderated by Chris Israel<\/strong> (Executive Director of the Alliance of U.S. Startups & Inventors for Jobs).<\/span><\/p>\nIn the wake of the recent House Judiciary Committee hearing on “Medicines and IP: Balancing Innovation and Access,” the panel unpacked prevailing narratives surrounding pharmaceutical patenting, innovation, and generic competition. Drawing on new IPPI research<\/a> on so-called “patent thickets” and “evergreening,” the discussion examined how pharmaceutical patents reflect the complex, ongoing process of developing and improving medicines — and why simplistic patent counting and common critiques of pharmaceutical patenting often fail to align with real-world evidence.<\/span><\/p>\n
\nJune 10 Webinar: <\/b>“IP at America’s 250th”<\/strong><\/h3>\nJoin us on Wednesday, June 10, from 1:00-2:30 PM EDT, for \u201cIP at America\u2019s 250th,\u201d a virtual panel co-hosted by the Council for Innovation Promotion<\/a> and IPPI: The IP Policy Institute as part of the WIPO-U.S. Summer School on IP<\/a>!<\/span><\/p>\nAmerica was born innovative. The Founders embedded intellectual property protection directly into the Constitution, and for 250 years the nation’s patent, copyright, trademark, and trade secret laws have powered everything from the cotton gin to the smartphone, and from the first American novel to the global entertainment industry.<\/span><\/p>\nThis panel marks America’s 250th by telling the story of IP from the ground up. Whether you’re a practitioner, a policy wonk, or simply curious about the legal foundations of American ingenuity, you won’t want to miss this conversation with a group of seasoned IP experts, including Victoria Cundiff<\/a>, David Gooder<\/a>, The Hon. Andrei Iancu<\/a>, and Karyn Temple<\/a> as panelists, with Joshua Kresh<\/a> as moderator.<\/span><\/p>\n
\nNew Policy Research on the Myths of
\n“Patent Thickets” and “Evergreening”<\/strong><\/h3>\nWe\u2019re pleased to share\u00a0new policy research by IPPI scholars that separates myth from reality in current debates over pharmaceutical patents.<\/span><\/p>\nIn this\u00a0collection of short papers<\/a>\u2014”Pharmaceutical ‘Patent Thickets’ <\/strong>and\u00a0“Pharmaceutical Patent ‘Evergreening'”<\/strong>\u2014Mark Schultz<\/strong> and Douglas Park<\/strong> of IPPI: The Intellectual Property Policy Institute at The University of Akron School of Law, together with\u00a0Jennifer Brant<\/strong>, IPPI Practitioner in Residence and Senior Advisor at Sidley, challenge common narratives about pharmaceutical patenting practices with real-world evidence.<\/span><\/p>\n
\n2026 WIPO-U.S. Summer School on IP<\/strong><\/h3>\n<\/a><\/figure>\nLearn more<\/strong><\/span><\/a><\/p>\n
\nBlog Post: “If AI Can Pirate the Internet, Why Can\u2019t You?”<\/strong><\/h3>\nBy David Atkinson | May 11, 2026<\/strong><\/span><\/p>\nRead the blog post<\/a><\/strong><\/span><\/p>\n
\nBlog Post: “Most-Favored-Nation (MFN) Drug Pricing: You Can\u2019t Import European Prices Without Importing European Tradeoffs”<\/strong><\/h3>\nBy Dr. Gabriela Lenarczyk | May 4, 2026<\/span><\/strong><\/p>\nRead the blog post<\/span><\/strong><\/a><\/p>\n
\nIPPI 2026 Spring Progress Report<\/strong><\/h3>\n(December 2025 – February 2026)<\/strong><\/span><\/p>\nRead the report<\/strong><\/a><\/span><\/p>\n
\nIPPI 2026 Winter Institute:<\/strong>
\n IP and National Success<\/em><\/strong><\/h3>\n<\/a><\/figure>\nHosted in partnership with<\/span>
\nThe University of Akron School of Law’s Winter Institute 2026<\/a><\/span><\/p>\nThursday, February 26, 2026<\/strong><\/span><\/p>\n
Learn more about the Fellowship and how to apply<\/strong><\/span><\/a><\/p>\n (June – August 2026)<\/strong><\/span><\/p>\n Read the report<\/strong><\/span><\/a><\/p>\n <\/p>\n<\/div>\n Wednesday, October 7, 2026<\/b><\/span> Join counsel and amici participating in\u00a0Sedlik v. Von Drachenberg<\/em>, No. 24-3367 (9th Cir. 2026) for an analysis of the Ninth Circuit\u2019s en banc rehearing just days after oral argument.<\/p>\n Learn more, register, and pre-submit questions.<\/span><\/strong><\/a><\/p>\n Webinar will not be recorded. Please join us live!<\/strong><\/p>\n<\/div>\n <\/p>\n By Michael Doane | July 20, 2026<\/strong><\/span><\/p>\n Read the blog post<\/strong><\/span><\/a><\/p>\n By Michael Doane | June 30, 2026<\/strong><\/span><\/p>\n Read the blog post<\/strong><\/span><\/a><\/p>\n (March – May 2026)<\/strong><\/span><\/p>\n Read the report<\/strong><\/span><\/a><\/p>\n In an exclusive webinar on Thursday, June 18th, 2026,<\/strong> IPPI scholars examined the myths and realities of pharmaceutical patents.<\/span><\/p>\n The conversation featured Mark Schultz<\/strong> (Faculty Chair & Senior Scholar, IPPI) and Emily Michiko Morris<\/strong> (Associate Faculty Chair, Senior Fellow for Life Sciences, & Senior Scholar, IPPI) and was moderated by Chris Israel<\/strong> (Executive Director of the Alliance of U.S. Startups & Inventors for Jobs).<\/span><\/p>\n In the wake of the recent House Judiciary Committee hearing on “Medicines and IP: Balancing Innovation and Access,” the panel unpacked prevailing narratives surrounding pharmaceutical patenting, innovation, and generic competition. Drawing on new IPPI research<\/a> on so-called “patent thickets” and “evergreening,” the discussion examined how pharmaceutical patents reflect the complex, ongoing process of developing and improving medicines — and why simplistic patent counting and common critiques of pharmaceutical patenting often fail to align with real-world evidence.<\/span><\/p>\n Join us on Wednesday, June 10, from 1:00-2:30 PM EDT, for \u201cIP at America\u2019s 250th,\u201d a virtual panel co-hosted by the Council for Innovation Promotion<\/a> and IPPI: The IP Policy Institute as part of the WIPO-U.S. Summer School on IP<\/a>!<\/span><\/p>\n America was born innovative. The Founders embedded intellectual property protection directly into the Constitution, and for 250 years the nation’s patent, copyright, trademark, and trade secret laws have powered everything from the cotton gin to the smartphone, and from the first American novel to the global entertainment industry.<\/span><\/p>\n This panel marks America’s 250th by telling the story of IP from the ground up. Whether you’re a practitioner, a policy wonk, or simply curious about the legal foundations of American ingenuity, you won’t want to miss this conversation with a group of seasoned IP experts, including Victoria Cundiff<\/a>, David Gooder<\/a>, The Hon. Andrei Iancu<\/a>, and Karyn Temple<\/a> as panelists, with Joshua Kresh<\/a> as moderator.<\/span><\/p>\n We\u2019re pleased to share\u00a0new policy research by IPPI scholars that separates myth from reality in current debates over pharmaceutical patents.<\/span><\/p>\n In this\u00a0collection of short papers<\/a>\u2014”Pharmaceutical ‘Patent Thickets’ <\/strong>and\u00a0“Pharmaceutical Patent ‘Evergreening'”<\/strong>\u2014Mark Schultz<\/strong> and Douglas Park<\/strong> of IPPI: The Intellectual Property Policy Institute at The University of Akron School of Law, together with\u00a0Jennifer Brant<\/strong>, IPPI Practitioner in Residence and Senior Advisor at Sidley, challenge common narratives about pharmaceutical patenting practices with real-world evidence.<\/span><\/p>\n Learn more<\/strong><\/span><\/a><\/p>\n By David Atkinson | May 11, 2026<\/strong><\/span><\/p>\n Read the blog post<\/a><\/strong><\/span><\/p>\n By Dr. Gabriela Lenarczyk | May 4, 2026<\/span><\/strong><\/p>\n Read the blog post<\/span><\/strong><\/a><\/p>\n (December 2025 – February 2026)<\/strong><\/span><\/p>\n Read the report<\/strong><\/a><\/span><\/p>\n Hosted in partnership with<\/span> Thursday, February 26, 2026<\/strong><\/span><\/p>\n
\nIPPI 2026 Fall Progress Report<\/strong><\/h3>\n
\nOctober 7 Webinar: <\/b>“<\/strong>The Future of Copyright\u2019s Substantial Similarity Doctrine: <\/strong>Insights from the En Banc Rehearing in Sedlik v. Von Drachenberg<\/em><\/strong>“<\/strong><\/h3>\n
<\/a>
\n1:30-3:00 p.m. Eastern \/ <\/b>10:30 a.m.-12:00 Noon Pacific<\/b><\/span><\/p>\n
\nNew Blog Post:<\/strong> “Proposed Litigation Funding Disclosure Rules at the U.S. International Trade Commission”<\/strong><\/h3>\n
\nRecent Letters and Comments by IPPI or Affiliates (June & July 2026)<\/strong><\/h3>\n<\/div>\n
\n
\nNew Blog Post:<\/strong> “Nominations to the U.S. International Trade Commission – A Complete Slate of Commissioners (Almost)”<\/strong><\/h3>\n
\nIPPI 2026 Summer Progress Report<\/strong><\/h3>\n
\nJune 18 Webinar: <\/b>“The Myths and Realities of Pharmaceutical Patents”<\/strong><\/h3>\n
\nJune 10 Webinar: <\/b>“IP at America’s 250th”<\/strong><\/h3>\n
\nNew Policy Research on the Myths of
\n“Patent Thickets” and “Evergreening”<\/strong><\/h3>\n
\n2026 WIPO-U.S. Summer School on IP<\/strong><\/h3>\n
<\/a><\/figure>\n
\nBlog Post: “If AI Can Pirate the Internet, Why Can\u2019t You?”<\/strong><\/h3>\n
\nBlog Post: “Most-Favored-Nation (MFN) Drug Pricing: You Can\u2019t Import European Prices Without Importing European Tradeoffs”<\/strong><\/h3>\n
\nIPPI 2026 Spring Progress Report<\/strong><\/h3>\n
\nIPPI 2026 Winter Institute:<\/strong>
\n IP and National Success<\/em><\/strong><\/h3>\n<\/a><\/figure>\n
\nThe University of Akron School of Law’s Winter Institute 2026<\/a><\/span><\/p>\n